Organizational update - New board member and new CFO
Kirsti Gjellan is new board member of OxThera as of 19 May 2020. “It is my pleasure to welcome Kirsti to the board of OxThera”, said Dr. Georges Gemayel, Chairman of Oxthera. “Her deep biologic manufacturing experience and successful track record of business leadership over her career will be of important value to Oxthera in its development of Oxabact for treating Primary hyperoxaluria.” “I am honored to join OxThera”, says Kirsti Gjellan. “I believe the company is poised to make a real difference in patients suffering from this devastating rare disease. I am excited to share my